Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.

end-stage kidney disease equity ethical framework kidney replacement therapy reimbursement social justice

Journal

Kidney international supplements
ISSN: 2157-1724
Titre abrégé: Kidney Int Suppl (2011)
Pays: United States
ID NLM: 101562008

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 26 06 2019
revised: 11 10 2019
accepted: 07 11 2019
entrez: 10 3 2020
pubmed: 10 3 2020
medline: 10 3 2020
Statut: ppublish

Résumé

Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.

Identifiants

pubmed: 32149010
doi: 10.1016/j.kisu.2019.11.004
pii: S2157-1716(19)30018-8
pmc: PMC7031686
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e63-e71

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):491-492
pubmed: 30898874
Lancet. 2012 Mar 17;379(9820):e36-8
pubmed: 22405254
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
Lancet Glob Health. 2017 Sep;5(9):e875-e887
pubmed: 28728918
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):74-77
pubmed: 27469149
Kidney Int. 2018 Sep;94(3):440-445
pubmed: 30143062
Lancet Glob Health. 2017 Apr;5(4):e408-e417
pubmed: 28229924
Perit Dial Int. 2001;21 Suppl 3:S314-7
pubmed: 11887843
Kidney Int Rep. 2018 Jul 27;3(5):1027-1029
pubmed: 30197968
Semin Nephrol. 2017 May;37(3):273-286
pubmed: 28532556
Kidney Int. 2011 Dec;80(12):1258-70
pubmed: 21993585
Med J Islam Repub Iran. 2017 Aug 27;31:47
pubmed: 29445676
Clin Kidney J. 2018 Oct;11(5):726-733
pubmed: 30288270
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):61-63
pubmed: 27469161
Bull World Health Organ. 2018 Jul 1;96(7):442
pubmed: 29962543
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):23-26
pubmed: 27469146
Health Policy Plan. 2012 Mar;27 Suppl 1:i4-12
pubmed: 22388499
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):523-529
pubmed: 30898873
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):29-33
pubmed: 27509582
Kidney Int Rep. 2018 Dec 20;4(3):390-398
pubmed: 30899866
Kidney Int Suppl (2011). 2016 Dec;6(2):42-51
pubmed: 30675419
Lancet. 2006 Oct 28;368(9546):1524-34
pubmed: 17071286
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):64-68
pubmed: 27469148
Kidney Int. 2016 Dec;90(6):1164-1174
pubmed: 27884311
BMJ. 2013 Jan 31;346:f462
pubmed: 23369775
Kidney Int. 2006 Sep;70(6):1107-14
pubmed: 16883316
Kidney Int. 2019 Apr;95(4S):S1-S33
pubmed: 30904051
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93
pubmed: 30545819
Perit Dial Int. 2007 Mar-Apr;27(2):142-8
pubmed: 17299147
Clin J Am Soc Nephrol. 2010 Apr;5(4):637-44
pubmed: 20167688
Int J Med Inform. 2019 May;125:47-54
pubmed: 30914180
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):78-83
pubmed: 27879188
Semin Nephrol. 2017 May;37(3):287-295
pubmed: 28532557
Bull World Health Organ. 2014 Jun 1;92(6):389
pubmed: 24940009
PLoS One. 2016 Oct 4;11(10):e0164201
pubmed: 27701466
Rev Med Inst Mex Seguro Soc. 2016 Sep-Oct;54(5):588-93
pubmed: 27428340
Dev World Bioeth. 2015 Dec;15(3):233-40
pubmed: 24953161
BMC Nephrol. 2018 Feb 2;19(1):28
pubmed: 29394930

Auteurs

Wim Van Biesen (W)

Nephrology Department, Ghent University Hospital, Ghent, Belgium.

Vivekanand Jha (V)

George Institute for Global Health India, New Delhi, India.
Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India.

Ali K Abu-Alfa (AK)

Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Sharon P Andreoli (SP)

Department of Pediatrics, Pediatric Nephrology, Indiana University Medical Center, Indianapolis, Indiana, USA.

Gloria Ashuntantang (G)

Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde, Yaounde I, Cameroon.

Bassam Bernieh (B)

Home Hemodialysis for Home Dialysis, Al Ain, United Arab Emirates.
The Heart Medical Center, Al Ain, United Arab Emirates.

Edwina Brown (E)

Imperial College Healthcare National Health Service Trust, London, UK.

Yuqing Chen (Y)

Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.

Rosanna Coppo (R)

Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.

Cecile Couchoud (C)

French Renal Epidemiology and Information Network (REIN) Registry, Biomedicine Agency, Paris, France.

Brett Cullis (B)

Renal Unit, Greys Hospital, Pietermaritzburg, South Africa.

Walter Douthat (W)

Hospital Privado-Universitario de Cordoba and Instituto Universitario de Ciencias Biomédicas, Cordoba, Argentina.

Felicia U Eke (FU)

Department of Pediatrics, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.

Brenda Hemmelgarn (B)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Fan Fan Hou (FF)

State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Nathan W Levin (NW)

Mount Sinai Icahn School of Medicine, New York, New York, USA.

Valerie A Luyckx (VA)

Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland.
Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Rachael L Morton (RL)

National Health and Medical Research Council Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.

Mohammed Rafique Moosa (MR)

Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.

Fliss E M Murtagh (FEM)

Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.

Marie Richards (M)

SEHA Dialysis Services, Abu Dhabi, United Arab Emirates.

Eric Rondeau (E)

Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sorbonne Université, Paris, France.

Daniel Schneditz (D)

Otto Loewi Research Center, Medical University of Graz, Graz, Austria.

Kamal D Shah (KD)

NephroPlus Dialysis Centres, Hyderabad, India.

Vladimir Tesar (V)

Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.

Karen Yeates (K)

Division of Nephrology, Queen's University, Kingston, Ontario, Canada.

Guillermo Garcia Garcia (G)

Servicio de Nefrologia, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Hospital 278, Guadalajara, Jalisco, Mexico.

Classifications MeSH